Journal of Medicinal Chemistry p. 2042 - 2049 (1989)
Update date:2022-08-03
Topics:
Bell, Andrew S.
Campbell, Simon F.
Roberts, David A.
Ruddock, Keith S.
A series of 7-heteroaryl-1,2,3,5-tetrahydroimidazo<2,1-b>quinazolin-2(1H)-ones was synthesized and evaluated in dogs for cardiac stimulant activity.Compounds were obtained by a palladium-catalyzed cross-coupling reaction between a heteroarylzinc chloride and a 7-iodo-1,2,3,5-tetrahydroimidazo<2,1-b>quinazolin-2(1H)-one or by cyclization of an N-<(2-aminophenyl)methyl>glycinate with cyanogen bromide.Compared to the parent ring system (3), introduction of a 2,6-dimethylpyridin-3-yl (6), 2,4-dimethylimidazol-1-yl (7), or 1,2,4-triazol-1-yl (8) moiety at the 7-position led to a 13-17-fold increase in positive inotropic activity (percentage increase in dP(dtmax) in anesthetized dogs.Potency could be further enhanced with a 9-methyl substituent (10-12).The most potent member of the series, 7-(2,4-dimethylimidazol-1-yl)-9-methyl-1,2,3,5-tetrahydroimidazo<2,1-b>quinazolin-2(1H)-one (11) (23percent increase in dP/dtmax, 2 μg/kg), was 80 times more active than 3 and displayed a 5-fold advantage over milrinone.In conscious dogs, 6 elicited marked and sustained positive inotropic activity (decrease in QA interval) after oral administration (1 mg/kg), whereas 10-12 were 10 times more potent. 11 produced an obvious increase in cardiac contractility (20percent increase in dP/dtmax) at low dose levels (25 μg/kg) while, after 100 μ/kg, the marked response (50percent increase in dP/dtmax) was maintained for the whole 7-h test period.In these experiments, 11 had no effect on heart rate, and the compound also displayed exceptional selectivity for increasing the force rather than the rate of cardiac contraction (> 150percent increase in dP/dtmax) in the Starling heart-lung preparation.These studies demonstrate that the tetrahydroimidazoquinazolinone nucleus is an effective bioisostere for the 2(1H)-quinolinone system and that 11 displays improved cardiac stimulant activity and duration of action when compared to milrinone.
View MoreContact:+86-22-26358246
Address:601-4-20, Fujiayuan, Tiantai Road, Hebei District, Tianjin, China
Luyunjia Chemistry Xiamen Limited
Contact:86-592-5360779
Address: Huli District, Xiamen, China
Contact:+86-371-67759225
Address:No.32, Jinsuo Road, High-tech Zone
Contact:Tel:+86-29-88764861 Fax:+86-29-88764861
Address:Rm#2107, Block A, Epin Meidao Building, Gaoxin Rd, Hi-Tech Zone, Xi’an, China
lianyungang jinkang pharmaceutical technology co., ltd.
Contact:008651885445517
Address:Jinshan industrial park, Ganyu county, Lianyungang, Jiangsu Province, 222115, China
Doi:10.1016/S0022-328X(00)88563-0
(1980)Doi:10.1016/j.bmc.2010.05.020
(2010)Doi:10.1016/j.polymer.2009.12.023
(2010)Doi:10.1016/S0040-4039(99)00807-2
(1999)Doi:10.1016/j.ica.2012.04.002
(2012)Doi:10.1016/S0040-4039(01)80274-4
(1989)